Evidence map›Paper›PMID 34630579›Full record

ArticleIranian journal of parasitology

Evaluation of Cellular Immune Responses in Dogs Immunized with Alum-Precipitated Autoclaved

Mohammad Barati, Mehdi Mohebali, Ali Khamesipour, Fariborz Bahrami, Haiedeh Darabi, Vahid Khaze, Farhad Riazi-Rad, Gholamreza Habibi, Soheila Ajdary, Mohammad Hossein Alimohammadian

Open access · goldAbstract read
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mohammad BaratiDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Mehdi MohebaliDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Ali KhamesipourCenter for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
Fariborz BahramiDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Haiedeh DarabiDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Vahid KhazeDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Farhad Riazi-RadDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Gholamreza HabibiRazi Vaccine & Serum Research Institute, Karaj, Iran.
Soheila AjdaryDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Mohammad Hossein AlimohammadianDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Pasteur Institute of Iran · IRTehran University of Medical Sciences · IRRazi Vaccine and Serum Research Institute · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to investigate the potential effects of BCG and imiquimod on improvement of current experimental

methodsDuring 2012 till 2014, seven mixed-breed shepherd dogs with no anti-

resultsAlthough a similar LST conversion was observed at all time-points, the cytokine measurement results indicated significantly higher levels of IFN-γ at day 80 and elevated levels of IL-10 at days 80 and 300, post-vaccination. Moreover, a significantly higher IFN-γ/IL-10 ratio was observed at day 30 post-vaccination compared to the other time-points.

conclusionAlthough a Th1-like response could be observed at day 30 post-vaccination, the development of cytokine profiles was inclined toward mixed Th1 and Th2 responses at days 80 and 300 post-vaccination. This situation may indicate the requirement of an additional boosting by this Alum-AML formula, in order to induce long-lasting protection against ZVL.

Indexed as

Alum-ALM vaccineBCG and imiquimod adjuvantCytokinesLeishmanin skin test (LST)Zoonotic visceral leishmaniasis (ZVL)

Identifiers

PMID34630579
PMCPMC8476724
OpenAlexW3198524159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.